Qube Research & Technologies (QRT)
EVGN icon

Qube Research & Technologies (QRT)’s Evogene EVGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5
Closed -$33 – 3524
2024
Q2 		$33 Hold
5
– – ﹤0.01% 3541
2024
Q1 		$37 Hold
5
– – ﹤0.01% 4229
2023
Q4 		$42 Hold
5
– – ﹤0.01% 4081
2023
Q3 		$29 Buy
+5
New +$44 ﹤0.01% 3858

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RIG
Renaissance Investment Group Lenox, Massachusetts $508M AUM 30.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVGN Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Evogene (EVGN) in Q3 2024, closing a stake of 5 shares — an estimated $33 sold.

Qube Research & Technologies (QRT) first reported a position in EVGN in Q3 2023 and held it in 4 quarters. The position peaked at $42 in Q4 2023. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5 Evogene shares in Q3 2024, an estimated $33.
  • Qube Research & Technologies (QRT) first reported a position in Evogene in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Evogene position peaked at $42 in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.